Toyomasa Katagiri
Directeur/Bestuurslid bij Cancer Precision Medicine KK
Profiel
Toyomasa Katagiri is currently the Director at Immunas Pharma, Inc. since 2014, Professor & Deputy Director at The University of Tokushima since 2008, and Director at Cancer Precision Medicine KK since 2018.
Previously, he served as an Outside Director at OncoTherapy Science, Inc. from 2010 to 2023.
Actieve functies van Toyomasa Katagiri
| Bedrijven | Functie | Begin |
|---|---|---|
| The University of Tokushima | Corporate Officer/Principal | 01-05-2008 |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Directeur/Bestuurslid | 01-12-2014 |
| Cancer Precision Medicine KK | Directeur/Bestuurslid | 01-05-2018 |
Eerdere bekende functies van Toyomasa Katagiri
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Directeur/Bestuurslid | 31-03-2023 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
| Cancer Precision Medicine KK |
